Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition

Molecular Therapy : the Journal of the American Society of Gene Therapy
Olivier ter BrakeBen Berkhout

Abstract

Human immunodeficiency virus type 1 (HIV-1) replication in T cells can be inhibited by RNA interference (RNAi) through short hairpin RNA (shRNA) expression from a lentiviral vector. However, for the development of a durable RNAi-based gene therapy against HIV-1, multiple shRNAs need to be expressed simultaneously in order to avoid viral escape. In this study, we tested a multiple shRNA expression strategy for different shRNAs using repeated promoters in a lentiviral vector. Although highly effective in co-transfection experiments, a markedly reduced activity of each expressed shRNA was observed in transduced cells. We found that this reduced activity was due to recombination of the expression cassette repeat sequences during the transduction of the lentiviral vector, which resulted in deletions of one or multiple cassettes. To avoid recombination, we tested different promoters for multiple shRNA expression. We compared the activity of the human polymerase III promoters U6, H1, and 7SK and the polymerase II U1 promoter. Activities of these promoters were similar, irrespective of which shRNA was expressed. We showed that these four expression cassettes can be combined in a single lentiviral vector without causing recombination. M...Continue Reading

References

Jan 11, 2000·Journal of Virology·A E JetztJ P Dougherty
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·G MarzioB Berkhout
Oct 9, 2001·Human Gene Therapy·M KumarR E Sutton
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Apr 12, 2002·Journal of Hepatology·Jurgen SeppenRonald P J Oude Elferink
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jenn-Yah YuDavid L Turner
Oct 22, 2002·Journal of Virology·Jianling ZhuangJoseph P Dougherty
Aug 9, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ming-Jie LiJohn J Rossi
Aug 22, 2003·Nucleic Acids Research·Daniel BodenBharat Ramratnam
Oct 15, 2003·Journal of Virology·Daniel BodenBharat Ramratnam
Feb 14, 2004·Journal of Virology·Atze T DasBen Berkhout
Jul 27, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Michela Alessandra DentiIrene Bozzoni
Oct 21, 2004·Biological Chemistry·Dorota Koper-EmdeBernd-Joachim Benecke
Dec 28, 2004·Nature Medicine·Vira BitkoSailen Barik
Feb 3, 2005·Nucleic Acids Research·Ellen M WesterhoutBen Berkhout
Feb 11, 2005·Gene Therapy·R Wolkowicz, G P Nolan
Apr 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Scott Q HarperBeverly L Davidson
Jun 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·David S StrayerJohn A Zaia
Mar 28, 2006·FEBS Letters·Ben Berkhout, Joost Haasnoot
Jun 24, 2006·BMJ : British Medical Journal·Steven G Deeks
Jul 29, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Scot D HenryLuc J W van der Laan
Sep 5, 2006·Retrovirology·Ellen M WesterhoutBen Berkhout
Sep 9, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Olivier ter BrakeBen Berkhout
Sep 9, 2006·Science·Manuel LlanoEric M Poeschla
Oct 26, 2006·Medical Care·Bruce R SchackmanKenneth A Freedberg
Nov 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bruce L LevineCarl H June
Feb 22, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dirk Grimm, Mark A Kay
Apr 5, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Joseph AndersonRamesh Akkina
Jul 14, 2007·The Journal of Gene Medicine·Olivier ter Brake, Ben Berkhout
Aug 24, 2007·Nucleic Acids Research·Ying Poi LiuBen Berkhout
Sep 27, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·David AndersonChris Denning

❮ Previous
Next ❯

Citations

Aug 10, 2011·Pharmaceutical Research·Priya S Shah, David V Schaffer
Nov 26, 2010·Cancer Gene Therapy·W GuN A J McMillan
Aug 13, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ying Poi LiuBen Berkhout
Mar 19, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mario AmendolaLuigi Naldini
Aug 26, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cecilia FrechaEls Verhoeyen
May 24, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Partha K ChandraSrikanta Dash
Sep 5, 2013·Molecular Therapy. Nucleic Acids·Mireille CentlivreBen Berkhout
Jul 10, 2010·Human Gene Therapy·Cheryl Y BrownSimon C Barry
Mar 19, 2008·Nucleic Acids Research·Ying Poi LiuPavlina Konstantinova
Aug 7, 2009·Nucleic Acids Research·Ying Poi LiuBen Berkhout
Dec 6, 2011·Nucleic Acids Research·Nishant ThakurManoj Kumar
Feb 5, 2013·Nucleic Acids Research·Ying Poi LiuBen Berkhout
May 19, 2010·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Atze T Das, Ben Berkhout
Nov 9, 2011·Antimicrobial Agents and Chemotherapy·Nick C T SchopmanBen Berkhout
Oct 13, 2010·BMC Molecular Biology·Luke S LambethVenugopal Nair
Apr 19, 2011·Genetic Vaccines and Therapy·Glen J McIntyreGregory C Fanning
Jun 10, 2010·Retrovirology·Nick C T SchopmanBen Berkhout
Jan 14, 2011·AIDS Research and Therapy·Glen J McIntyreTanya L Applegate
Dec 20, 2012·RNA·Rasmus O BakJacob Giehm Mikkelsen
Oct 25, 2011·PloS One·Atul TyagiManoj Kumar
Oct 11, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jiehua Zhou, John J Rossi
Dec 18, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elena Herrera-CarrilloBen Berkhout

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
gene knock-down
fluorescence-activated cell sorting
PCRs
PCR
FACS
transfections
Assay
enzyme-linked immunosorbent assay
nucleic acid oligonucleotides

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.